- Exchange: Toronto
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Valeant Pharmaceuticals International Inc
+ Add to WatchlistVRX:CN
87.0000 CAD 10.1600 13.22%As of 16:00:28 ET on 05/24/2013.
Company Profile for Valeant Pharmaceuticals International Inc (VRX)
Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders, and distributes generic and branded generic drugs in Latin America and Eastern Europe.
Contact Information
Valeant Pharmaceuticals International Inc
4787 Levy Street
Montreal, PQ H4R 2P9
Canada
Key Executives for Valeant Pharmaceuticals International Inc (VRX)
| J Michael Pearson "Mike"Chairman/CEO | Michel ChouinardChief Operating Officer |
| Howard B SchillerExec VP/CFO | Ryan H WeldonExec VP/Chair:U.S. Dermatology |
| Robert R Chai-OnnExec VP/Secretary/General Cnsl | Brian M StolzExec VP:Administration |
| Susan T HallSenior VP/Global Head:Research | Laurie W LittleVP:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page